Experiences from Germany

Prof. Jürgen Wolf

Home > Oncology > ELCC 2019

Read the full Report (pdf)

European Lung Cancer Conference

10–13 April 2019, Geneva, Switzerland

Featured articles

Letter from the editor

Editor

Dr Stefan Rauh, Centre Hospitalier Emile Mayrisch, Esch, Luxembourg

Conference

ELCC 2019

25 June, 2019 13:48

Electromagnetic navigation bronchoscopy

Presented By

Dr Kelvin Lau, St Bartholomew’s Hospital, London, United Kingdom

Trial

NAVIGATE

Conference

ELCC 2019

25 June, 2019 13:10

Online First

Current Management of Early Stage NSCLC

Tumour, node, and metastasis (TNM) staging system

Presented By

Dr Walter Weder, Dr Ramón Rami-Porta

Conference

ELCC 2019

25 June, 2019 23:02

Treatment options in early NSCLC

Presented By

Dr Walter Weder, Dr Raffaele Califano

Trial

CALGB 9633

Conference

ELCC 2019

25 June, 2019 13:04

Trial Data: Early Stage Lung Cancer

Electromagnetic navigation bronchoscopy

Presented By

Dr Kelvin Lau, St Bartholomew’s Hospital, London, United Kingdom

Trial

NAVIGATE

Conference

ELCC 2019

25 June, 2019 13:10

Genomic and immune profiling

Presented By

Dr Ke-Zhong Chen, Peking University People’s Hospital, Beijing, China

Conference

ELCC 2019

25 June, 2019 13:08

Immunotherapy in Stage 4 Lung Cancer

I-O monotherapy

Presented By

Prof. Martin Reck, Airway Research Center North, Grosshansdorf, Germany

Trial

CheckMate 026, Keynote-024, Checkmate 227, MYSTIC, B-F1RST

Conference

ELCC 2019

25 June, 2019 23:13

Combo I-O plus chemotherapy

Presented By

Dr Luis Paz-Ares, Complutense University of Madrid, Spain

Trial

Keynote-189, Impower-132

Conference

ELCC 2019

25 June, 2019 22:15

Other I-O combinations

Presented By

Prof. Solange Peters, Lausanne University Hospital and Ludwig Institute, Switzerland

Trial

IMpower 150

Conference

ELCC 2019

25 June, 2019 21:17

Predictive diagnostics for I-O

Presented By

Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain

Trial

Phase 3, BFAST

Conference

ELCC 2019

25 June, 2019 13:19

Trials: Immunotherapy in Stage 4 Lung Cancer

Post-discontinuation immunotherapy in PACIFIC

Presented By

Dr Phillip Dennis, Dr Marina Garassino

Trial

Phase 3, PACIFIC

Conference

ELCC 2019

25 June, 2019 23:23

Post-study immunotherapy in MYSTIC

Presented By

Dr Niels Reinmuth, Asklepios Lung Clinic, Munich-Gauting, Germany

Trial

Phase 3, MYSTIC

Conference

ELCC 2019

25 June, 2019 13:26

Implementation of Personalised Lung Cancer Care in Clinical Routine